Suchergebnisse - "F0P408N6V4"

PubPharm (3.160)

1

Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Jedlowski, P. | DuPont, J.

2

Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B

enthalten in: Photodermatology, photoimmunology & photomedicine | 2024

von De Novellis, D. | Raimondo, A. | Serio, B. | +4

3

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

enthalten in: Blood cancer journal | 2024

von Callander, N. | Silbermann, R. | Kaufman, J. | +33

4

Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes : the HOVON89 trial

enthalten in: Leukemia | 2024

von van de Loosdrecht, A. | Cremers, E. | Alhan, C. | +37

5

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

6

SuFEx-based chemical diversification for the systematic discovery of CRBN molecular glues

enthalten in: Bioorganic & medicinal chemistry | 2024

von Carter, T. | Milosevich, N. | Dada, L. | +4

7

Myelodysplastic syndromes del(5q) : Pathogenesis and its therapeutic implications

enthalten in: European journal of haematology | 2024

von Bruzzese, A. | Martino, E. | Mendicino, F. | +7

8

Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma

enthalten in: Journal for immunotherapy of cancer | 2024

von Coffey, D. | Osman, K. | Aleman, A. | +10

9

Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML

enthalten in: Blood | 2024

von Bourgeois, W. | Cutler, J. | Aubrey, B. | +22

CommentIn: Blood. 2024 Apr 11;143(15):1438-1439. - PMID 38602697

10

The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma : Considerations on behalf of the Chronic Malignancies Working Party of the EBMT

enthalten in: British journal of haematology | 2024

von Hwang, A. | Hayden, P. | Pawlyn, C. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[316]